Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · IEX Real-Time Price · USD

0.860

+0.082 (10.60%)

At close: Apr 26, 2024, 4:00 PM

0.856

-0.005 (-0.53%)

After-hours: Apr 26, 2024, 7:59 PM EDT

Ginkgo Bioworks Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-892.87	-2,104.93	-1,830.05	-126.61	-119.33
Depreciation & Amortization	99.87	63.51	29.08	13.86	10.76
Share-Based Compensation	229.88	1,931	1,606	0.48	0.77
Other Operating Activities	267.62	-141.42	-58.87	-23.56	63.14
Operating Cash Flow	-295.5	-252.2	-253.82	-135.83	-44.66
Capital Expenditures	-36.37	-52.27	-56.52	-57.82	-22.22
Acquisitions	-43.33	-20.99	-12.04	-10.1	0
Change in Investments	0	6.31	-4.7	0.8	-52.38
Other Investing Activities	-0.99	-0.44	-	-	-
Investing Cash Flow	-80.69	-67.39	-73.26	-67.12	-74.6
Share Issuance / Repurchase	-0.49	98.08	1,485	0.03	-0.4
Debt Issued / Paid	-1.3	-1.24	-1.12	-0.75	198.61
Other Financing Activities	-1.43	-1.5	50.47	91.04	212.18
Financing Cash Flow	-3.22	95.34	1,534	90.32	410.39
Exchange Rate Effect	-0.59	0.91	-0.02	0	0
Net Cash Flow	-380	-223.35	1,207	-112.63	291.12
Free Cash Flow	-331.87	-304.47	-310.34	-193.65	-66.88
Free Cash Flow Margin	-131.98%	-63.74%	-98.89%	-252.62%	-123.43%
Free Cash Flow Per Share	-0.17	-0.18	-0.23	-0.15	-0.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).